Advertisements



Experimental treatment uses modified stem cells to fight cancer

Daniel Apodaca is a 25-year-old film student at UCLA. He's also the first patient in a clinical trial that's testing a treatment using genetically modified bone marrow stem cells to fight cancer......»»

Category: videoSource: cnnJul 20th, 2018

FDA approves bladder cancer treatment by Culver City company

The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer.The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer......»»

Category: topSource: latimesApr 23rd, 2024

Elias Animal Health seeks $10M for first-of-its-kind treatment, names new exec

Elias Animal Health is preparing to launch its first product, a potentially revolutionary bone cancer treatment for dogs......»»

Category: topSource: bizjournalsApr 10th, 2024

AnPac Bio approves joint venture to develop new cancer treatment technology

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2021

Metastatic colon cancer patient saved by aggressive treatment

In late summer 2017, Laura Perez made two trips to the Children’s Mercy emergency department with abdominal pain. When Perez’s pain grew worse, she was admitted to the hospital for extensive tests. At just 18, she was diagnosed with colon c.....»»

Category: topSource: bizjournalsMay 17th, 2021

Skin cancer: Myths, detection, treatment and prevention

Most of us at one time or another have experienced the painful redness, peeling and even blistering resulting from a sunburn, but there are also longer-term problems such as early aging of the skin (brown spots or wrinkles) and skin cancer. Accordin.....»»

Category: topSource: bizjournalsMay 15th, 2021

Genprex in-licenses gene therapy technologies for lung cancer treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2021

ChemoCentryx"s stock dives after critique from the FDA about experimental treatment for rare autoimmune disease

Shares of ChemoCentryx Inc. plunged 44.8% in trading on Tuesday after the Food and Drug Administration questioned the rat.....»»

Category: topSource: marketwatchMay 4th, 2021

BioLine RX rockets on heavy volume after "strikingly positive" trial data on cancer treatment

Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»

Category: topSource: marketwatchMay 4th, 2021

Lilly to donate experimental COVID-19 treatment Olumiant to India

Lilly to donate experimental COVID-19 treatment Olumiant to India.....»»

Category: topSource: marketwatchMay 4th, 2021

: The fight over SALT is heating up. What’s next?

The State and Local Tax deduction cap is a lightning rod, pitting higher-cost, mostly blue states against those who think it represents preferential treatment. What can we expect from Washington?.....»»

Category: topSource: marketwatchMay 3rd, 2021

Reviva"s stock jumps after experimental schizophrenia drug meets endpoint in Phase 2 clinical trial

Shares of Reviva Pharmaceuticals Holdings Inc. soared 76.6% in trading on Monday after the company said its experimental treatment .....»»

Category: topSource: marketwatchApr 26th, 2021

AstraZeneca"s Tagrisso recommended in E.U. for treatment of EGFR lung cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021

Vertex to study experimental gene-editing therapy as treatment for sickle cell, beta-thalassemia

Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»

Category: topSource: marketwatchApr 21st, 2021

Sorrento"s Human Derived Mesenchymal Stem Cells Achieves 100% Discharge Rate In Critically-Ill COVID-19 Patients

read more.....»»

Category: blogSource: benzingaApr 20th, 2021

FDA approves Bristol-Myers" Opdivo for initial treatment of gastric cancer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2021

NovoCure surges 65% to all-time high on upbeat review of its lung cancer treatment trial

"Pending regulatory approval, the recommended protocol adjustments could accelerate trial completion by more than a year," its CEO said. In this phot.....»»

Category: personnelSource: nytApr 13th, 2021

I"ve tested hundreds of skincare products as a beauty editor and this facial exfoliator is still my favorite - I"ve been using it for over a decade

This cult-classic exfoliating treatment dissolves dead skin cells within two minutes. It left my skin the smoothest it has ever been. If you buy through our links, we may earn money from affiliate partners......»»

Category: worldSource: nytApr 9th, 2021

Aikido Secures Sublicense For Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients

read more.....»»

Category: blogSource: benzingaApr 7th, 2021

Exclusive: Precigen"s CEO Breaks Down Biotech"s Oncology Platforms, Technology, Differentiators

Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to immunotherapies to new, personalized therapeutics. read more.....»»

Category: blogSource: benzingaApr 6th, 2021

Emergent says experimental COVID-19 treatment failed in Phase 3 trial

Emergent BioSolutions Inc. said Fr.....»»

Category: topSource: marketwatchApr 2nd, 2021